Charles River Laboratories International, Inc. (CRL)
340.41
-0.40
(-0.12%)
USD |
NYSE |
Nov 13, 16:00
340.41
0.00 (0.00%)
After-Hours: 19:59
Charles River Laboratories International Price to Book Value : 5.050 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 5.056 |
| November 11, 2026 | 5.084 |
| November 10, 2026 | 5.130 |
| November 09, 2026 | 5.242 |
| November 06, 2026 | 5.008 |
| November 05, 2026 | 4.644 |
| November 04, 2026 | 4.841 |
| November 03, 2026 | 5.220 |
| November 02, 2026 | 5.023 |
| October 30, 2026 | 5.332 |
| October 29, 2026 | 5.580 |
| October 28, 2026 | 5.548 |
| October 27, 2026 | 5.324 |
| October 26, 2026 | 5.300 |
| October 23, 2026 | 5.124 |
| October 22, 2026 | 5.039 |
| October 21, 2026 | 5.116 |
| October 20, 2026 | 4.68 |
| October 19, 2026 | 4.451 |
| October 16, 2026 | 4.453 |
| October 15, 2026 | 4.543 |
| October 14, 2026 | 4.480 |
| October 13, 2026 | 4.436 |
| October 12, 2026 | 4.478 |
| October 09, 2026 | 4.477 |
| Date | Value |
|---|---|
| October 08, 2026 | 4.421 |
| October 07, 2026 | 4.455 |
| October 06, 2026 | 4.524 |
| October 05, 2026 | 4.611 |
| October 02, 2026 | 4.305 |
| October 01, 2026 | 4.255 |
| September 30, 2026 | 4.377 |
| September 29, 2026 | 4.974 |
| September 28, 2026 | 4.951 |
| September 25, 2026 | 4.922 |
| September 24, 2026 | 4.949 |
| September 23, 2026 | 4.661 |
| September 22, 2026 | 4.792 |
| September 21, 2026 | 4.690 |
| September 18, 2026 | 4.674 |
| September 17, 2026 | 4.734 |
| September 16, 2026 | 4.595 |
| September 15, 2026 | 4.586 |
| September 14, 2026 | 4.590 |
| September 11, 2026 | 4.677 |
| September 10, 2026 | 4.588 |
| September 09, 2026 | 4.678 |
| September 08, 2026 | 4.719 |
| September 04, 2026 | 4.849 |
| September 03, 2026 | 4.931 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Fortrea Holdings, Inc. | 3.660 |
| IQVIA Holdings, Inc. | 6.557 |
| Medpace Holdings, Inc. | 31.17 |
| Champions Oncology, Inc. | 16.73 |
| Avantor, Inc. | 1.803 |
Price to Book Value Related Metrics
| PE Ratio | 377.31 |
| PS Ratio | 4.168 |
| Price to Free Cash Flow | 41.48 |
| Price | 340.41 |
| Earnings Yield | 0.27% |
| Market Cap | 16.30B |
| Operating PE Ratio | 27.12 |
| Normalized PE Ratio | 44.19 |